🇺🇸 FDA
Patent

US 9556232

Anti-angiogenic molecules, nanostructures and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 9556232 (Anti-angiogenic molecules, nanostructures and uses thereof) held by Northwestern University expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P35/00